EPPK1 and inherited lipid metabolism disorder: Our study confirmed key proteins (PCSK9, ANGPTL3, LPA), identified potential novel targets (GSTA1, GSTA3, EPPK1, PECR, and PLA2G15), and strengthened evidence for CELSR2 and GAS6 in dyslipidaemia.